Background Cardiac allograft vasculopathy(CAV) is a significant obstacle to improving outcomes in heart transplant recipients.

• 研究背景：移植心脏血管病(Cardiac allograft vasculopathy，CAV)是影响心脏移植病人长期存活的主要障碍。